The Pharmaceuticals sector has seen immense growth in the recent times. Research-led major pharma companies are looking at the growing domestic markets and other markets like UAE. Amidst increasing competition in the space, companies are challenged to understand the industry, for peak revenue estimates, to get a better patent environment, pricing and market access.

 
Clients engage UC to assist them with market access, peak revenues estimates, entry strategies, business plans and pricing and reimbursement. UC has assessed the market for a novel breast cancer molecule in India and Turkey and the Indian market for therapeutic neurotoxins. UC has also assessed the Japanese and EU NDDS market for Parkinsons. We have also developed a growth strategy for the diabetes care segment by using an integrated approach spanning diagnostics, therapeutics and nutrition for a leading MNC in India.